Release Date

March 24, 2015

Valid for credit through

March 31, 2016

Estimated Time to Complete Activity:

30 minutes per activity for a total of 1.5 hours

TARGET AUDIENCE

Cardiologists, internists, primary care physicians, RNs, NPs, PAs, pharmacists, and other healthcare professionals who care for patients with dyslipidemia.

STATEMENT OF NEED/PROGRAM OVERVIEW

This CME/CE program addresses scientific advancements in monoclonal antibody therapy and the management of patients with dyslipidemia. The unique educational format of this initiative includes a learner driven, interactive, on-demand, webcast structured as three 20-minute modules that will each be delivered using the unique ArcheMedX Platform. This program aims to arm health care providers with information on disease management, diagnosis, and emergent clinical trial data in order to improve the care administered to patients with dyslipidemia. The interactive set-up of this CME program will provide an optimal learner experience, resulting in greater quality care for patients in practice.

Faculty

Christopher Cannon, MD
Cardiovascular Medicine
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School                                      
Boston, MA

Peter P. Toth, MD, PhD
Director of Preventative Cardiology
CGH Medical Center
Clinical Professor
University of Illinois College of Medicine
Peoria, IL

Michael J. Koren, MD
CEO, Jacksonville Center for Clinical Research
Past President, Academy of Physicians in Clinical Research
Jacksonville, FL

Robert S. Rosenson, MD
Professor of Medicine
Director of Cardiometabolic Disorders
Icahn School of Medicine at Mount Sinai
New York, NY

Accreditation

0.50 AMA PRA Category 1 Credit(s)TM  for physicians, per module
0.5 contact hours for pharmacists (0.05 CEUs), per module
0.4 and 0.3 contact hours for nurses (module 1 and 2, 0.4 CE's; module 3, 0.3 CE's)

Activities